THOMAS, MCNERNEY & PARTNERS
Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in life science and medical technology companies. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors as well as in other areas utilizing medical technology innovation. Companies developing therapeutic products for life threatening or costly, chronic conditions are of particular interest. Thomas, McNern... ey & Partners invests in companies at all stages of their development. In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization. The partnership also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies as well as recapitalizations.
THOMAS, MCNERNEY & PARTNERS
Industry:
Life Science Medical Venture Capital
Founded:
2003-01-01
Status:
Active
Contact:
203-978-2010
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps GoDaddy DNS ASP.NET IIS IIS 10 GoDaddy Parallels Plesk Panel
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Mission BioCapital
Mission BioCapital is a life science venture capital firm that invests in early-stage companies.
BioVenture
BioVenture is a Chinese venture capital firm that offers early and growth stage investment services.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-03-27 | VertiFlex | Thomas, McNerney & Partners investment in Venture Round - VertiFlex | 45.33 M USD |
| 2016-07-26 | Torax Medical | Thomas, McNerney & Partners investment in Series E - Torax Medical | 25 M USD |
| 2014-10-13 | Invitae | Thomas, McNerney & Partners investment in Series F - Invitae | 120 M USD |
| 2014-09-09 | SG Biofuels | Thomas, McNerney & Partners investment in Series C - SG Biofuels | 11 M USD |
| 2014-01-08 | Auspex Pharmaceuticals | Thomas, McNerney & Partners investment in Series E - Auspex Pharmaceuticals | 20 M USD |
| 2013-01-10 | AxioMed Spine | Thomas, McNerney & Partners investment in Series D - AxioMed Spine | 3.6 M USD |
| 2012-11-08 | Auspex Pharmaceuticals | Thomas, McNerney & Partners investment in Series D - Auspex Pharmaceuticals | 25 M USD |
| 2012-10-18 | Cebix | Thomas, McNerney & Partners investment in Series B - Cebix | 33.19 M USD |
| 2012-09-19 | Torax Medical | Thomas, McNerney & Partners investment in Series D - Torax Medical | 30 M USD |
| 2012-04-12 | Tioga Pharmaceuticals | Thomas, McNerney & Partners investment in Series B - Tioga Pharmaceuticals | 10 M USD |